The Promise of Dotinurad for Hyperuricemia in CKD

Amy S. Li, Pranav S. Garimella

Open source

DOI: 10.1016/j.ekir.2025.04.049
Published: 2025-06
Container: Kidney International Reports
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ekir.2025.04.049,
  title = {The Promise of Dotinurad for Hyperuricemia in CKD},
  author = {Amy S. Li and Pranav S. Garimella},
  year = {2025},
  journal = {Kidney International Reports},
  doi = {10.1016/j.ekir.2025.04.049},
  url = {https://doi.org/10.1016/j.ekir.2025.04.049}
}

RIS

TY  - JOUR
TI  - The Promise of Dotinurad for Hyperuricemia in CKD
AU  - Amy S. Li
AU  - Pranav S. Garimella
PY  - 2025
JO  - Kidney International Reports
DO  - 10.1016/j.ekir.2025.04.049
UR  - https://doi.org/10.1016/j.ekir.2025.04.049
ER  -

APA

Li, A. S., & Garimella, P. S. (2025). The Promise of Dotinurad for Hyperuricemia in CKD. Kidney International Reports. https://doi.org/10.1016/j.ekir.2025.04.049

Source records

crossref · retrieved 2026-11-07T23:20:24.717Z